July 24 (Reuters) - GALDERMA GROUP AG GALD.S:
H1 RECORD NET SALES OF 2.448 BILLION USD
DOUBLE-DIGIT GROWTH IN BOTH INTERNATIONAL MARKETS AND U.S., WITH STRONG PERFORMANCE ACROSS ALL PRODUCT CATEGORIES
GROWTH IN CORE EBITDA, DELIVERING 555 MILLION USD, UP 9.5% YEAR-ON-YEAR AT CONSTANT CURRENCY, WITH A SLIGHTLY HIGHER THAN EXPECTED CORE EBITDA MARGIN FOR FIRST HALF OF 22.7%
NET LEVERAGE REDUCED TO 2.1X
RAISING 2025 FULL-YEAR GUIDANCE ON NET SALES, EXPECTING GROWTH OF 12-14% AT CONSTANT CURRENCY (PREVIOUSLY 10-12%)
CONFIRMING GUIDANCE ON CORE EBITDA MARGIN OF APPROXIMATELY 23% AT CONSTANT CURRENCY
Source text: ID:nBw47Qhpra
Further company coverage: GALD.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))